🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/04/2005 | 20,29 | 21,00 | 19,99 | 20,25 | -2,70% | 4,98% | 242.881 |
| 07/04/2005 | 20,17 | 21,00 | 19,95 | 20,81 | +3,54% | 5,19% | 393.830 |
| 06/04/2005 | 20,10 | 20,40 | 19,88 | 20,10 | -0,19% | 2,61% | 714.163 |
| 05/04/2005 | 20,10 | 20,40 | 19,84 | 20,14 | +0,56% | 2,79% | 369.438 |
| 04/04/2005 | 20,29 | 20,85 | 19,73 | 20,03 | -5,81% | 5,54% | 674.729 |
| 01/04/2005 | 21,26 | 21,67 | 20,29 | 21,26 | -0,87% | 6,51% | 914.244 |
| 31/03/2005 | 20,55 | 21,52 | 19,88 | 21,45 | +3,99% | 8,01% | 769.734 |
| 30/03/2005 | 19,35 | 20,70 | 19,16 | 20,62 | +10,64% | 7,93% | 1.409.491 |
| 29/03/2005 | 21,86 | 21,90 | 18,64 | 18,64 | -15,31% | 14,90% | 2.131.643 |
| 28/03/2005 | 24,33 | 25,79 | 21,71 | 22,01 | -28,55% | 16,77% | 6.147.291 |
| 24/03/2005 | 29,08 | 31,29 | 28,90 | 30,80 | +6,47% | 8,24% | 786.084 |
| 23/03/2005 | 29,38 | 29,38 | 28,86 | 28,93 | -1,65% | 1,78% | 421.215 |
| 22/03/2005 | 29,42 | 29,79 | 29,08 | 29,42 | -0,38% | 2,42% | 476.144 |
| 21/03/2005 | 30,24 | 30,73 | 28,82 | 29,53 | -3,07% | 6,31% | 404.731 |
| 18/03/2005 | 29,31 | 30,84 | 28,90 | 30,47 | +5,03% | 6,64% | 2.211.900 |
| 17/03/2005 | 28,11 | 29,91 | 19,05 | 29,01 | -12,63% | 38,62% | 4.131.065 |
| 16/03/2005 | 32,26 | 33,72 | 31,78 | 33,20 | +2,31% | 6,03% | 697.839 |
| 15/03/2005 | 33,13 | 34,44 | 31,44 | 32,45 | -1,25% | 9,04% | 654.451 |
| 14/03/2005 | 33,09 | 33,65 | 31,85 | 32,86 | +0,23% | 5,43% | 669.199 |
| 11/03/2005 | 32,60 | 33,20 | 32,19 | 32,79 | +1,74% | 3,10% | 578.523 |
| 10/03/2005 | 33,05 | 33,69 | 31,59 | 32,23 | -2,71% | 6,34% | 428.054 |
| 09/03/2005 | 32,98 | 33,76 | 32,98 | 33,13 | -0,11% | 2,38% | 357.977 |
| 08/03/2005 | 34,32 | 34,44 | 33,13 | 33,16 | -3,49% | 3,82% | 782.398 |
| 07/03/2005 | 33,95 | 34,62 | 33,39 | 34,36 | +1,21% | 3,64% | 530.112 |
| 04/03/2005 | 34,77 | 35,71 | 33,72 | 33,95 | -3,92% | 5,70% | 457.176 |
| 03/03/2005 | 36,64 | 36,87 | 35,33 | 35,33 | -2,88% | 4,19% | 484.507 |
| 02/03/2005 | 36,87 | 37,24 | 34,51 | 36,38 | -1,42% | 7,41% | 600.190 |
| 01/03/2005 | 36,57 | 37,24 | 36,53 | 36,91 | +0,61% | 1,94% | 837.648 |
| 28/02/2005 | 37,24 | 37,62 | 36,49 | 36,68 | -1,80% | 3,02% | 460.061 |
| 25/02/2005 | 37,47 | 37,77 | 36,68 | 37,36 | +0,20% | 2,90% | 357.736 |